NATIONAL INSTITUTES OF HEALTH

WVU Cancer Institute's Shyam Thakkar, M.D., pioneers the use of the FDA-approved 180° C2 Cryoballoon for treating Barrett’s esophagus, a precancerous condition, enhancing safety and precision in esophageal cancer prevention.

New guidelines for AI use in brain cancer diagnosis and treatment ensure reliable clinical trial results and patient protection, addressing variability in radiologist interpretations and promoting objective AI analysis of tumor images.

Achieve Life Sciences reports Q3 2024 financials, completes ORCA-OL trial enrollment, presents at FDA/NIH meeting, receives Breakthrough Therapy designation for cytisinicline in vaping cessation, and announces leadership changes.

Stanford Institute for Human-Centered AI announces 29 graduate and postdoctoral fellows for 2024-25, representing diverse research areas including AI safety, digital health, energy science, and precision medicine. Fellows will collaborate with Stanford faculty on human-centered AI challenges.

Dr. Nora Volkow, Director of NIDA, discusses her mission to revolutionize addiction treatment, emphasizing the role of drugs in altering brain function and behavior. Her research explores new treatments like GLP1 medications and the importance of prevention strategies. Volkow's work bridges lab research and clinical application, aiming for immediate interventions and long-term systemic changes.

Researchers identified immune and stromal cell changes in the heart underlying myocarditis in cancer patients on immune checkpoint inhibitors, pinpointing blood factors indicating mortality risk. The study suggests distinct immune responses in the heart and tumor, potentially enabling targeted therapies for myocarditis while maintaining antitumor immunotherapy.

Myocarditis driven by distinct immune response from anti-tumor one, suggesting future management without halting cancer therapy.

Trump's re-election impacts healthcare, reproductive rights, and climate change. His health records remain undisclosed. Republican gains and Supreme Court appointments enhance his influence. Senate control facilitates presidential appointments.

Dr. Nora Volkow, NIDA Director, discusses her mission to revolutionize addiction treatment, emphasizing the need for critical interventions, novel prevention and treatment approaches, and the potential of GLP1 medications. She highlights the importance of prevention strategies and future research areas, bridging laboratory research and clinical application.